On Tuesday, Governor Kevin Stitt signed SB949 which moves the Oklahoma Film + Music Office (OF+MO) to the Oklahoma Department of Commerce (Commerce). OF+MO was previously part of the Oklahoma Tourism & Recreational Department. The bill takes effect on …
DANBURY, CT, April 29, 2021 (GLOBE NEWSWIRE) -- Ethan Allen Interiors Inc. (“Ethan Allen” or the “Company”) (NYSE: ETH) today reported its business and financial results for the fiscal 2021 third quarter ended March 31, 2021. The Company reported GAAP EPS …
The United States Supreme Court has issued an opinion in an immigration case. The court held that a notice to appear sufficient to trigger the Illegal Immigration Reform and Immigrant Responsibility Act of 1996’s stop-time rule is a single document …
TEMPE, Ariz., April 29, 2021 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (Nasdaq: WRAP) (the “Company”), a global leader in innovative public safety technologies and services, today announced results for its first quarter ended March 31, 2021 (“1Q21”). …
LOUISVILLE, Ky., April 29, 2021 (GLOBE NEWSWIRE) -- Texas Roadhouse, Inc. (NasdaqGS: TXRH), today announced financial results for the 13 week period ended March 30, 2021 and provided a business update. Statement from Jerry Morgan, CEO and President The …
The pandemic has taken its toll on children's mental and physical health. Soul Mates® is here to help them by activating their bodies and calming their minds. BARCELONA, CATALONIA, SPAIN, April 29, 2021 /EINPresswire.com/ -- World Alive S.L. are the …
SAN DIEGO, April 29, 2021 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report first quarter 2021 financial …
VALENCIA, Calif. and MELBOURNE, Australia, April 29, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (Company), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care …
CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi- …
BOISE, Idaho, April 29, 2021 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU), today announced the appointment of Sharawn Connors to the role of chief diversity and inclusion officer. Connors joined Micron in July 2019 as the vice president of …
NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will report its financial results for the first quarter ended March 31, 2021 on Thursday, May 6, 2021, after the close …
FORT LAUDERDALE, Fla., April 29, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the …
MARGENZA™ launched in mid-March Upcoming poster presentation of MGC018 initial Phase 1 clinical data at ASCO Conference call scheduled for today at 4:30 p.m. ET. ROCKVILLE, Md., April 29, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a …
OKLAHOMA CITY, April 29, 2021 (GLOBE NEWSWIRE) -- Mammoth Energy Services, Inc. (“Mammoth” or the “Company”) (NASDAQ: TUSK) today reported financial and operational results for the first quarter ended March 31, 2021. Financial Overview for the First …
IRVINE, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced …
First Quarter and Recent Highlights: Advanced discussions with several potential license and equipment supply partners Received first insurance payment of $1.4 million toward the business interruption claim, bringing total insurance collected to $25.0 …
REDWOOD CITY, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company focused on developing novel treatments with AMB-05X, its proprietary anti-CSF1R monoclonal antibody platform, today …
Southfield, Michigan, April 29, 2021 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) today announced consolidated net income of $202.1 million, or $11.82 per diluted …
Both vonoprazan-based treatment regimens demonstrated superior eradication rates vs. a standard of care proton pump inhibitor (PPI)-based triple therapy New Drug Application (NDA) submissions targeted for Q4 2021 Phathom to host conference call and live …
- Revenue Growth Accelerated to 53% Over Prior-Year-Period to $31.2 Million - - Core Revenue Growth Accelerated to 47% Over Prior-Year-Period to $26.7 Million - - Total Written Premium Growth Accelerated to 49% over Prior Year Period - - Total Franchises …
